Takeda Pharmaceutical Co. TAK

18.86 0.27 1.45% as of 25 Sep
Market cap
$59.2B
P/E
28.4×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Total current assets
11,724.16 9,709.27 27,455.92 22,718.77 25,501.19 23,083.41 17,744.88 17,654.20 16,639.87 20,397.32
Total non-current assets
28,784.63 27,248.90 97,394.98 95,235.30 95,874.37 94,200.94 85,542.48 86,596.47 77,399.20 81,978.63
Total Assets
40,508.77 36,958.17 124,850.90 117,954.10 121,375.60 117,284.40 103,287.40 104,250.70 94,039.07 102,375.90
Total current liabilities
12,704.65 6,637.58 22,598.38 20,018.26 16,667.85 19,097.00 18,366.36 15,960.41 16,543.04 18,691.69
Total non-current liabilities
9,678.76 12,163.91 55,780.23 54,442.93 56,042.24 47,604.02 37,896.43 38,099.63 31,718.57 34,641.98
Total liabilities
22,383.41 18,801.49 78,378.61 74,461.20 72,710.09 66,701.01 56,262.78 54,060.04 48,261.61 53,333.66
Common Equity (Total)
18,125.37 18,156.68 46,472.29 43,492.87 48,665.46 50,583.35 47,024.57 50,190.63 45,777.46 49,042.29
Shareholders Equity (Total)
18,125.38 18,156.68 46,472.29 43,492.87 48,665.46 50,583.36 47,024.57 50,190.63 45,777.46 49,042.29
Total Debt
10,647.48 8,870.96 51,758.56 46,858.40 43,572.49 38,674.16 32,429.32 33,421.89 29,800.75 32,220.13

Show all line items

In millions of $ except per-share values · columns are period end dates